Abstract
Introduction: Cardiac hypertrophy is a leading predictor of heart failure. The mechanisms that drive cardiac hypertrophy are poorly understood from a molecular and cellular perspective, due to the lack of knowledge of the governing signaling. Hypothesis and Aims: I hypothesize that there exist genes that regulate hypertrophy beyond the field’s current understanding that can be identified by combining the publicly available, high-throughput International Mouse Phenotyping Consortium (IMPC) database with network modeling. I aim to use a large-scale network model of cardiac hypertrophy to assess the IMPC genes’ effects on hypertrophic phenotypes and validate these findings in vitro to identify novel regulators. Materials & Methods: The IMPC was established by worldwide mouse clinics using in vivo models to perform single gene knockout experiments with primary phenotyping, forming a database with ~9000 genes, ~1000 of which can be associated with cardiac hypertrophy. 1 st neighbors (genes directly interacting with the hypertrophy network model as evidenced by protein-protein interaction databases) were identified and effects on hypertrophy were assessed through the IMPC and network model knockdown simulations. When both methods suggested hypertrophic regulation, a gene was considered a candidate regulator. siRNA experiments are being performed in neonatal rat cardiomyocytes for validation. High-content imaging and qPCR are used to quantify changes in phenotype and confirm gene knockdown. Results: Combining the IMPC with protein-protein interaction data, 37 1 st neighbor genes were identified. Knockdown simulation identified 2 genes (LRIG1, CBL) as negative regulators. 3 genes (VAV2, LEPR, RASA1) were identified as positive regulators. These genes became candidates for in vitro validation given the network-wide hypertrophic effects enacted by their knockdowns. siRNA experiments are being optimized to fully validate modeling findings. Conclusions: Mechanistic modeling identified 5 genes as novel regulators of cardiac hypertrophy. Sensitivity analysis highlighted known influencers of hypertrophy in the knockdown context. siRNA knockdown experiments are being performed to validate the model predictions.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.